Achieve Life Sciences (ACHV) Cash from Operations (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Cash from Operations data on file, last reported at 6932000.0 in Q1 2026.

• Quarterly Cash from Operations rose 37.48% year-over-year to 6932000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 45344000.0 (down 27.48% YoY) and the FY2025 annual result came in at 49500000.0, down 66.27% from the prior year.
• Cash from Operations advanced to 6932000.0 in Q1 2026, from 18012000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 4364000.0 in Q4 2023 to a low of 18012000.0 in Q4 2025.
• A 5-year average of 8720588.24 and a median of 8340000.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations tumbled 113.55% — and 2023, when it soared 60.84%.
• Tracing ACHV's Cash from Operations over 5 years: stood at 11143000.0 in 2022, then soared by 60.84% to 4364000.0 in 2023, then slumped by 110.56% to 9189000.0 in 2024, then plunged by 96.02% to 18012000.0 in 2025, then surged by 61.51% to 6932000.0 in 2026.
• The last three Cash from Operations figures came in at 6932000.0 (Q1 2026), 18012000.0 (Q4 2025), and 11288000.0 (Q3 2025), per Business Quant data.